Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,418
Closed -$3.06M 83
2024
Q4
$3.06M Buy
4,418
+3,719
+532% +$2.67M 1.03% 25
2024
Q3
$582K Hold
699
0.2% 72
2024
Q2
$715K Sell
699
-585
-46% -$562K 0.22% 68
2024
Q1
$1.25M Sell
1,284
-213
-14% -$189K 0.39% 53
2023
Q4
$1.13M Hold
1,497
0.34% 53
2023
Q3
$881K Sell
1,497
-255
-15% -$169K 0.28% 63
2023
Q2
$1.27M Hold
1,752
0.34% 60
2023
Q1
$1.19M Hold
1,752
0.35% 57
2022
Q4
$957K Sell
1,752
-3,600
-67% -$1.89M 0.28% 65
2022
Q3
$2.22M Buy
5,352
+2,590
+94% +$1.3M 0.54% 45
2022
Q2
$1.31M Buy
+2,762
New +$1.54M 0.41% 57

Other funds holding ASML

Kerrisdale Advisers's ASML Position: Q1 2025 in Review

Kerrisdale Advisers sold out of ASML (ASML) in Q1 2025, closing a stake of 4,418 shares — an estimated $3.06M sold.

Kerrisdale Advisers first reported a position in ASML in Q2 2022 and held it in 11 quarters. The position peaked at $3.06M in Q4 2024. 1,622 funds tracked by Wall St. Rank hold ASML as of Q1 2025.

  • Kerrisdale Advisers reported no remaining ASML position as of Q1 2025 after selling out during the quarter.
  • Kerrisdale Advisers sold 4,418 ASML shares in Q1 2025, an estimated $3.06M.
  • Kerrisdale Advisers first reported a position in ASML in Q2 2022 and held it in 11 quarters.
  • Kerrisdale Advisers's ASML position peaked at $3.06M in Q4 2024.
  • 1,622 funds tracked by Wall St. Rank held ASML as of Q1 2025.

Based on Kerrisdale Advisers's 13F filing for Q1 2025, filed 15 May 2025.